Probiotic prophylaxis in predicted severe acute pancreatitis

The Lancet

Volumn 372, Issue 9633, 2008, Pages 113-114

  Marteau, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACUTE PANCREATITIS; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG MEGADOSE; ENTERIC FEEDING; ENTEROCOLITIS; HUMAN; INTESTINE ISCHEMIA; LACTIC ACID BACTERIUM; LETTER; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; INTESTINE; ISCHEMIA; NOTE; VASCULARIZATION; ANIMAL; COLON; FERMENTATION; METABOLISM; PANCREATITIS;

ENTERAL NUTRITION; HUMANS; INTESTINES; ISCHEMIA; PROBIOTICS; ANIMALS; COLON; FERMENTATION; PANCREATITIS;

EID: 46949095106     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61026-0     Document Type: Letter

References (4)

1. Besselink M., van Santvoort H., Buskens E., et al., for the Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
2. van Minnen L., Timmerman H., Lutgendorff F., et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 141 (2007) 470-480
3. Marteau P., and Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 17 (2003) 725-740
4. Alfaleh K., and Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 1 (2008) CD005496.